Enclomiphene vs. Clomiphene: A Comparative Analysis for Scientists

Enclomiphene and clomiphene are two synthetic compounds belonging to the estrogen inhibitor group or SERM. Researchers are investigating them in studies related to infertility, low libido, and hypogonadism in preclinical models. Let us understand in detail Enclomiphene VS Clomiphene. What these compounds are, their differences, and how they influence these pathways. 

What is Enclomiphene?

Buy Enclomiphene

Enclomiphene is a synthetic compound that belongs to the estrogen inhibitor group. It is also known as sex or fertility medicine. In the medical world, it has been investigated in hypogonadism or fertility-related studies in laboratory experiments.  Early preclinical studies suggest its potential in inhibiting the parameters involved in estrogen secretion. In return, this potential of enclomiphene may affect testosterone secretion, muscle hypertrophy, and skeletal health in preclinical models. 

What is Clomiphene? 

Clomiphene is a mixture of two isomers: Enclomiphene and Zuclomiphene. It has similar properties to its parent compound, enclomiphene. It belongs to the category of SERM (selective estrogen receptor modulator). SERMs are those compounds that have the potential to modulate estrogen receptor activity.  As a SERM, clomiphene also demonstrates similar effects in laboratory studies. Early studies of the compound suggest that it may influence estrogen inhibition in preclinical models. The potential of estrogen inhibition may affect parameters related to testosterone secretion, ovulation, fertility, and muscle hypertrophy in preclinical models. 

Mechanism of Action

Both enclomiphene and clomiphene have similar mechanisms of action, as they belong to the same group, SERM. After being administered to preclinical models, it has been shown to reach the hypothalamus and influence parameters involving estrogen inhibition.  Estrogen inhibition may affect the pathways linked with LH (Luteinizing Hormone) and FSH (Follicle-Stimulating Hormone) in preclinical models. In return, the LH may affect testosterone pathways by improving its levels, whereas FSH may affect ovulation (egg formation) in preclinical models. Both these effects have been shown to impact infertility and low sexual hormone levels in preclinical models during laboratory studies.  

Side-by-Side Comparison of Enclomiphene and Clomiphene 

• Chemical Composition: Enclomiphene consists of only enclomiphene. In contrast, clomiphene consists of two isomers: enclomiphene and zuclomiphene. 

• Effects on Estrogen: Enclomiphene has more potent effects on estrogen as it belongs to the class of SERMs. On the other hand, clomiphene has shown both anti-estrogenic and estrogenic effects due to the combination of enclomiphene and zuclomiphene. 

• Effects on Testosterone: Enclomiphene has shown a more substantial influence on testosterone, and researchers have observed an increase in its levels. On the other hand, clomiphene may also affect testosterone levels, but in a moderate way in preclinical models. 

• Half-Life Duration: Enclomiphene has shown a shorter half-life, whereas clomiphene has shown a longer duration in preclinical models due to the presence of zuclomiphene. Zuclomiphene may persist for weeks in preclinical models during laboratory studies. 

• Side Effects: The side effects of enclomiphene may be mild to moderate, ranging from hot flashes to irritation. On the other hand, clomiphene may have moderate side effects, ranging from visual disturbance, hot flashes, and irritation, among others. These mild side effects are due to the presence of an extra isomer: zuclomiphene. 

Research Applications/Potential Benefits

The potential benefits/research applications of enclomiphene and clomiphene are as follows: 

Potential Benefits of Enclomiphene: 

• It may regulate sexual hormonal levels in preclinical models by impacting testosterone and estrogen levels. 
• It may regulate fertility and ovulation in preclinical models. 
• It has shown an influence on hypogonadism (low testosterone levels).
• This impact on testosterone may influence libido in preclinical models. 
• Improved libido may also reduce fatigue and mood swings in preclinical models. 
• Testosterone influence may also affect muscle hypertrophy. 
• Improved testosterone levels may also affect skeletal health and bone integrity in preclinical models.

Potential Benefits of Clomiphene: 

• Clomiphene may regulate sexual hormonal balance in preclinical models. 
• Clomiphene may also impact the parameters linked with estrogen inhibition in preclinical models. 
• It may also affect luteinizing and follicle-stimulating hormone levels. 
• The LH and FSH may impact libido and sexual desires in preclinical models. 
• Clomiphene may also affect ovulation and hypogonadism in preclinical models. 
• It may also impact muscle hypertrophy and skeletal health integrity in preclinical models. 

Side Effects

Enclomiphene: 

• Occasional dizziness
• Mild fatigue
• Mild headache
• Hot flashes
• Irritation

Clomiphene: 

• Temporary hormonal imbalance
• Headaches
• Irritation
• Hot flashes
• Visual disturbance
• Estrogenic activity

Note: These side effects were observed during early studies on the compound; therefore, they may vary from subject to subject. Further research is still being conducted to explore these compounds.

Regulatory Status

Both of them are strictly prohibited for human or veterinary use, as they are particularly designed for laboratory use. However, it is still widely used by researchers to deeply investigate and explore the compounds. For human use, a product should meet the criteria of the Food and Drug Administration of the United States.

Which One is Best?

At the moment, we cannot decide which one is best between them. They both have shown similar impacts on testosterone and estrogen in preclinical models with different side effects. The choice between them depends on the choice, objectives, and goals of a researcher. However, enclomiphene has shown mild side effects with well-established research results. Therefore, researchers are focusing on enclomiphene for investigating hypogonadism and infertility in preclinical models.

Conclusion

Enclomiphene and clomiphene are two synthetic compounds that belong to SERMs (selective estrogen receptor modulators). Clomiphene has an extra isomer known as zuclomiphene. They have been shown to influence the parameters associated with infertility, sexual desires, and hypogonadism in preclinical models. Besides similar impacts, they differ in the intensity of side effects. 

Frequently Asked Questions (FAQs) 

What is enclomiphene used for in laboratory studies?

Enclomiphene is used to investigate infertility, low libido, and hypogonadism in preclinical models in laboratory studies. 

What are the differences between enclomiphene and clomiphene? 

They both belong to the Selective Estrogen Receptor Modulator (SERM). They differ in chemical composition, half-life, and the intensity of side effects. Clomiphene has two isomers known as enclomiphene and zuclomiphene, a long half-life, and moderate side effects in preclinical models. On the other hand, enclomiphene has a short half-life and mild side effects in experimental settings. 

Is enclomiphene good for muscle hypertrophy in preclinical settings? 

Yes, enclomiphene may be good for muscle hypertrophy in preclinical settings. Its impacts on the testosterone levels may influence muscle hypertrophy in preclinical models. However, researchers are investigating it to fully explore its potential. 

Is clomiphene legal? 

It is only legal for laboratory studies. Its human consumption is strictly prohibited as it has not yet been approved by the FDA. 

What is the mechanism of action of clomiphene? 

In preclinical studies, clomiphene may influence the hypothalamus to inhibit estrogen secretion in preclinical models. Estrogen inhibition may affect the pathways linked with LH and FSH, regulating ovulation and hypogonadism in experimental settings.